Please login to the form below
Porter Novelli strengthens health and wellness team
Matthew Foster joins the London agency as a director
Porter Novelli has appointed Matthew Foster as a director in its London health and wellness practice.
Foster joins the public relations agency from AbbVie, where he served as senior corporate communications manager responsible for all external and above-brand communications.
Prior to this, he worked at both Waggener Edstrom and Hill & Knowlton as an account director, and also brings experience from Amgen, Tonic Life Communications and Burson-Marsteller.
Nicole Yost, head of health and wellness at Porter Novelli London, said: “As PN London continues to grow and expand as a hub for global communications, Matthew's in-house experience and viewpoint helps us further strengthen our health and wellness practice.”
COVID-19 Updates and Daily News
Featured jobs
- FDA sets November date for expert panel review of Biogen’s aducanumab
- Moderna completes enrolment of phase 3 COVID-19 vaccine trial
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Roche and Prothena set to advance Parkinson’s disease candidate into phase 2b
- Vaccine developers call on FDA to offer clarity on COVID-19 trials
- How will the events and exhibitions industry change post-Coronavirus?
- Novartis weathers the COVID-19 storm in Q3, lifts outlook
- Eli Lilly ends COVID-19 antibody trial in hospitalised setting, other studies continue
- Researchers say COVID-19 antibody levels have fallen rapidly in the UK
- Exploring the potential of eosinophils
- Eliminating pharmaceutical rebates, is this déjà vu?
- Bayer pays an initial $2bn for gene therapy firm AskBio
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Exploring the potential of eosinophils
- GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
- Eliminating pharmaceutical rebates, is this déjà vu?
- By Andrew Parece and Matthew Majewski...
- Patients are ready to embrace decentralised clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Quick links
Infographics
